Valsalva maneuver in pulmonary arterial hypertension: Susceptibility to syncope and autonomic dysfunction

Chest

Volumn 149, Issue 5, 2016, Pages 1252-1260

  Mar, Philip L ^a,e   Nwazue, Victor ^a   Black, Bonnie K ^a   Biaggioni, Italo ^a,b   Diedrich, André ^a,c   Paranjape, Sachin Y ^a   Loyd, James E ^a   Hemnes, Anna R ^a   Robbins, Ivan M ^a   Robertson, David ^a,b   Raj, Satish R ^a,b,f   Austin, Eric D ^d  

^a Departments of Clinical Pharmacology Core   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e University of Louisville School of Medicine   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autonomic function; Autonomic nervous; Pulmonary arterial hypertension; Syncope

Indexed keywords

ADRENERGIC BAROREFLEX SENSITIVITY; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FAINTNESS; FEMALE; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PRESSURE RECOVERY TIME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; VALSALVA MANEUVER; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; HEMODYNAMICS; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; BAROREFLEX; BLOOD PRESSURE; CASE-CONTROL STUDIES; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; SYNCOPE; VALSALVA MANEUVER;

EID: 84966680810     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2015.11.015     Document Type: Article

References (23)

1. McGoon MD, Benza RL, Escribano-Subias P, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol. 2013;62(25 Suppl): D51-D59.
2. Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med. 2005;143(4):282-292.
3. James TN. On the cause of syncope and sudden death in primary pulmonary hypertension. Ann Intern Med. 1962;56: 252-264.
4. Rajdev A, Garan H, Biviano A. Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis. 2012;55(2):180-186.
5. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250-2294.
6. Opotowsky AR, Ojeda J, Rogers F, et al. Blood pressure response to the Valsalva maneuver. A simple bedside test to determine the hemodynamic basis of pulmonary hypertension. J Am Coll Cardiol. 2010;56(16):1352-1353.
7. Harris PA, Scott KW, Lebo L, et al. ResearchMatch: a national registry to recruit volunteers for clinical research. Acad Med. 2012;87(1):66-73.
8. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42-D50.
9. Novak P. Assessment of sympathetic index from the Valsalva maneuver. Neurology. 2011;76(23):2010-2016.
10. Fox IJ, Crowley WP Jr., Grace JB, et al. Effects of the Valsalva maneuver on blood flow in the thoracic aorta in man. J Appl Physiol. 1966;21(5):1553-1560.
11. Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology. 2005;65(10):1533-1537.
12. Schrezenmaier C, Singer W, Swift NM, et al. Adrenergic and vagal baroreflex sensitivity in autonomic failure. Arch Neurol. 2007;64(3):381-386.
13. Korner PI, Tonkin AM, Uther JB. Reflex and mechanical circulatory effects of graded Valsalva maneuvers in normal man. J Appl Physiol. 1976;40(3):434-440.
14. Folino AF, Bobbo F, Schiraldi C, et al. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung. 2003;181(6):321-328.
15. Low PA, Denq JC, Opfer-Gehrking TL, et al. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve. 1997;20(12): 1561-1568.
16. McGowan CL, Swiston JS,Notarius CF, et al. Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension. Heart. 2009;95(9): 754-758.
17. Ciarka A, Doan V, Velez-Roa S, et al. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181(11):1269-1275.
18. Mak S, Witte KK, Al-Hesayen A, et al. Cardiac sympathetic activation in patients with pulmonary arterial hypertension. Am J Physiol Regul Integr Comp Physiol. 2012;302(10):R1153-R1157.
19. Low PA. Testing the autonomic nervous system. Semin Neurol. 2003;23(4):407-421.
20. Velez-Roa S, Ciarka A, Najem B, et al. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110(10):1308-1312.
21. Jackson G, Benjamin N, Jackson N, et al. Effects of sildenafil citrate on human hemodynamics. Am J Cardiol. 1999;83(5A):13c-20c.
22. Williamson DJ, Wallman LL, Jones R, et al. Hemodynamic effects of bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension. Circulation. 2000;102(4):411-418.
23. Packer M. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards. Ann Intern Med. 1985;103(2):258-270.